Fuji Pharma Co., Ltd. (TYO:4554)
Japan flag Japan · Delayed Price · Currency is JPY
2,526.00
+152.00 (6.40%)
At close: Mar 27, 2026

Fuji Pharma Ratios and Metrics

Millions JPY. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
65,94237,70330,95028,33725,12128,416
Market Cap Growth
97.62%21.82%9.22%12.80%-11.60%-26.98%
Enterprise Value
93,02162,37857,13754,04645,91937,050
Last Close Price
2526.001546.001234.741097.98943.041030.82
PE Ratio
26.4612.575.048.259.3211.68
Forward PE
17.2110.317.248.298.4712.03
PS Ratio
1.210.730.670.690.710.84
PB Ratio
1.380.800.680.690.700.87
P/TBV Ratio
1.941.140.940.920.990.94
P/FCF Ratio
-9.8722.54--12.89
P/OCF Ratio
-6.507.4614.78-4.74
PEG Ratio
-1.121.121.121.121.12
EV/Sales Ratio
1.701.211.241.321.301.09
EV/EBITDA Ratio
8.816.977.567.857.046.79
EV/EBIT Ratio
14.2512.5014.7214.0112.1511.06
EV/FCF Ratio
-16.3341.61--16.81
Debt / Equity Ratio
0.640.660.640.700.690.57
Debt / EBITDA Ratio
2.883.453.874.213.773.42
Debt / FCF Ratio
-8.1021.31--8.47
Net Debt / Equity Ratio
0.560.510.540.650.590.26
Net Debt / EBITDA Ratio
2.562.653.263.873.221.55
Net Debt / FCF Ratio
-6.2017.97-18.88-3.653.84
Asset Turnover
0.580.560.530.510.510.54
Inventory Turnover
1.491.581.511.391.501.70
Quick Ratio
0.830.820.660.630.681.10
Current Ratio
1.571.551.191.311.451.73
Return on Equity (ROE)
4.88%6.49%14.17%8.92%7.87%6.70%
Return on Assets (ROA)
4.31%3.40%2.77%3.00%3.38%3.32%
Return on Invested Capital (ROIC)
7.41%5.32%4.18%4.84%5.59%5.95%
Return on Capital Employed (ROCE)
10.40%8.00%7.20%6.90%7.30%7.60%
Earnings Yield
3.54%7.96%19.86%12.12%10.73%8.56%
FCF Yield
-10.13%4.44%-4.98%-22.91%7.76%
Dividend Yield
1.98%2.94%3.44%3.37%3.71%2.81%
Payout Ratio
-34.53%15.82%26.17%27.04%33.18%
Buyback Yield / Dilution
-0.50%-0.38%-0.04%-0.03%9.58%13.77%
Total Shareholder Return
1.50%2.56%3.40%3.34%13.29%16.58%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.